Reant P., Lafitte S., Labrousse L., et al. Validation and ischemia detection by simultaneous assessment of subendocardial and subepicardial circumferential, longitudinal and radial myocardial strains during dobutamine stress echocardiography (abstr). Eur Heart J 29 Suppl (2008) 794
Paulis D.D., Augeul L., Ovize M., Gharib A., and Derumeaux G.A. Early prediction of transmural extent of myocardial infarct by speckle tracking imaging after reperfusion in rats (abstr). Eur Heart J 29 Suppl (2008) 794
Mignot A., Donal E., Salem A., et al. Global longitudinal strain as a strong predictor of cardiac events in patients with depressed left ventricular function: a multicenter study (abstr). Eur Heart J 29 Suppl (2008) 795
Ramshorst J.V., Mollema S.A., van der Wall E.E., Schalij M.J., Atsma D.E., and Bax J.J. Immediate decrease in septal strain after septal ablation for hypertrophic obstructive cardiomyopathy is strongly associated with reduction in left ventricular outflow tract gradient after 6 months (abstr). Eur Heart J 29 Suppl (2008) 796
Detaint D., Brochet E., Iung B., Messika-Zeitoun D., and Vahanian A. Early hemodynamic changes during exercise are more related to the onset of dyspnea than peak hemodynamic values in patients with asymptomatic mitral stenosis. An echo-Doppler exercise study (abstr). Eur Heart J 29 Suppl (2008) 626
Lancellotti P., Donal E., Zacharakis D., Attena E., Cosyns B., and Pierard L. Assessment of left ventricular longitudinal myocardial reserve during exercise in asymptomatic patients with aortic stenosis (abstr). Eur Heart J 29 Suppl (2008) 192
Detaint D., Brochet E., Lepage L., et al. Significant paravalvular aortic regurgitation after percutaneous aortic valve implantation is related to aortic annulus size (abstr). Eur Heart J 29 Suppl (2008) 802
Detaint D., Messika-Zeitoun D., Brochet E., Iung B., Himbert D., and Vahanian A. Transesophageal echocardiography yields larger values than transthoracic in measurements of aortic annulus. Implications for percutaneous aortic valve implantation (abstr). Eur Heart J 29 Suppl (2008) 623-624
Bhan A., Kapetanakis S., Wilson K., et al. 2D vs. 3D transesophageal echo: is there a difference between the two when assessing aortic annular size for percutaneous aortic valve replacement (abstr)?. Eur Heart J 29 Suppl (2008) 390
Schepis T., Benz K., Haldemann A., Frielingsdorf J., and Eberli F.R. Prognostic value of stress technetium 99m-sestamibi SPECT in patients with multivessel coronary artery disease and previous coronary revascularization (abstr). Eur Heart J 29 Suppl (2008) 527
Galassi A.R., Tomasello S.D., Barrano G., et al. Long term outcome of patients with chronic total occlusions: the value of monitoring percutaneous coronary intervention by non-invasive imaging (abstr). Eur Heart J 29 Suppl (2008) 774
Tio R.A., Dabeshlim A., Siebelink H.M.J., et al. Myocardial perfusion reserve measured with PET scan is an independent prognostic factor in patients with coronary artery disease (abstr). Eur Heart J 29 Suppl (2008) 791-792
Masci P.G., Aquaro G.D., Strata E., et al. Significance of myocardial mild delayed enhancement on contrast-MRI in patients with hypertrophic cardiomyopathy (abstr). Eur Heart J 29 Suppl (2008) 494
Chan W.S., Luk C.H., Lee S., and Tse H.F. Comparison of prognostic value of computed tomography coronary angiogram and adenosine cardiac magnetic resonance perfusion imaging in patients presented with chest pain (abstr). Eur Heart J 29 Suppl (2008) 529
Aldrovandi A., Cademartiri F., Seitun S., et al. Prognostic value of coronary computed tomography in patients with suspected coronary artery disease: a single center clinical experience with 2 years follow-up (abstr). Eur Heart J 29 Suppl (2008) 151
Hadamitzky M., Meyer T., Hermann F., et al. Long term clinical follow-up of 16-slice coronary computed tomography: patients without coronary stenosis show an incidence rate for cardiovascular events of less than 1% per year (abstr). Eur Heart J 29 Suppl (2008) 151
Chang H.J., Choi S.I., Cho Y.S., et al. Impact of coronary CT angiography on the behavior of physicians and patients in asymptomatic population (abstr). Eur Heart J 29 Suppl (2008) 774
Fujitaka K., Nakamura S., Hatada K., et al. Combined analysis of multislice CT coronary angiography and stress myocardial perfusion imaging in detecting hemodynamically significant coronary artery stenosis (abstr). Eur Heart J 29 Suppl (2008) 528
van Werkhoven J.M., Schuijf J.D., Jukema J.W., et al. Evaluation of coronary artery disease; coronary stenosis on MSCT versus myocardial perfusion on MRI (abstr). Eur Heart J 29 Suppl (2008) 373
Faletra F., D'angeli I., Marcolongo A., et al. Reduction of dose radiation exposure by step-and-shoot protocol during cardiac multidetector computed tomography examination (abstr). Eur Heart J 29 Suppl (2008) 249
Rossebø A.B., Pedersen T.R., Boman K., et al., SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359 (2008) 1343-1356
Peto R., Emberson J., Landray M., et al. Analyses of cancer data from three ezetimibe trials. N Engl J Med 359 (2008) 1357-1366
Antonini-Canterin F., Hirsu M., Popescu B.A., et al. The effect of statins on the progression of aortic valve disease is stage-related. A long-term follow-up study in 1046 patients (abstr). Eur Heart J 29 Suppl (2008) 533
Simolin M.A., Pedersen T.X., Bro S., et al. ACE-inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model (abstr). Eur Heart J 29 Suppl (2008) 649
Herrmann S., Strotmann J., Niemann M., et al. Impact of myocardial fibrosis on patients with severe symptomatic aortic valve stenosis (abstr). Eur Heart J 29 Suppl (2008) 187-188
Grube E., Mueller R., Buellesfeld L., Sauren B., and Gerckens U. Acute and 1-month outcomes of percutaneous corevalve revalving aortic valve replacement in high risk patients with severe aortic stenosis: differences between the early 18F Safety & Efficacy trial (abstr). Eur Heart J 29 Suppl (2008) 780
Schofer J., Tuebler T., Treede H., et al. Initial experience with a stentless and retrievable percutaneous aortic valve prosthesis (abstr). Eur Heart J 29 Suppl (2008) 60
Weisenberg D., Omelchenko A., Shapira Y., et al. The natural history of moderate aortic regurgitation (abstr). Eur Heart J 29 Suppl (2008) 190
Fox K., Ford I., Steg P.G., Tendera M., Robertson M., Ferrari R., and BEAUTIFUL Investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372 (2008) 807-816
Fox K., Ford O., Steg P.G., Tendera M., Ferrari R., and BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008) 817-821
GISSI-HF Investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) Aug 29 [E-pub ahead of print]
GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) Aug 29 [E-pub ahead of print]
Frustaci A. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy. Paper presented at: European Society of Cardiology Congress; September 3 (2008) Munich, Germany
Angermann C.E., Stoerk S., Gelbrich G., et al. A novel non-pharmacological intervention to improve mortality and morbidity in patients with chronic heart failure (abstr). Eur Heart J 29 Suppl (2008) 509
Linde C. Progressive reverse remodeling in patients with mild or symptomatic heart failure with previous symptoms in the REsynchronization reVErses Remodelling in Systolic left vEntricular dysfunction (REVERSE) study. Paper presented at: European Society of Cardiology Congress; September 3 (2008) Munich, Germany
Lunati M., Santini M., Landolina M., et al. Intra-thoracic impedance for the assessment of heart failure hospitalization risk (abstr). Eur Heart J 29 Suppl (2008) 380
Landolina M., Vergara G., Lonardi G., et al. Reduction of heart failure hospitalizations in patients implanted with a defibrillator equipped with an alert system on intra-thoracic impedance (abstr). Eur Heart J 29 Suppl (2008) 380
Jacobshagen C., Unsoeld B.W., Seidler T., Schott P., Maier L.S., and Hasenfuss G. Large volume, ice-cold intravenous fluid for therapeutic hypothermia does not compromise the respiratory situation in patients after cardiac arrest (abstr). Eur Heart J 29 Suppl (2008) 265
Nagao K., Sakamoto T., Igarashi M., et al. Atropine for resuscitation after out-of-hospital cardiac arrest due to non-shockable rhythm (abstr). Eur Heart J 29 Suppl (2008) 264-265
Hasin Y., Danchin N., Filippatos G., et al., Working Group on Acute Cardiac Care of the European Society of Cardiology. Recommendations for the structure, organization, and operation of intensive cardiac care units. Eur Heart J 26 (2005) 1676-1682
Sanguino P.S., Lopez De Sa E., Pena-Conde L., et al. Do patients with ST segment elevation myocardial infarction in Killip class I need acute intensive cardiac care after a successful primary percutaneous intervention (abstr)?. Eur Heart J 29 Suppl (2008) 138
De Palma R., Smith E.J., Jones D.A., et al. Primary angioplasty can achieve successful early hospital discharge following myocardial infarction (abstr). Eur Heart J 29 Suppl (2008) 578
Mendiz O., Thomas M.R., Ahmed W.H., Roy K., and Mascioli S. Real-world experience with TAXUS Liberte: one-year results from the 22,000 patient OLYMPIA global post-approval registry (abstr). Eur Heart J 29 Suppl (2008) 517-518
Zahn R., Hamm C., Nienaber C., et al. Indications and outcome of sirolimus-eluting coronary stents in clinical practice in 11,070 patients. Final results from the German Cypher registry (abstr). Eur Heart J 29 Suppl (2008) 517
Sirbu V., Guagliumi G., Musumeci G., et al. In-vivo mechanisms of late drug eluting stent thrombosis. Optical coherence tomography, intravascular ultrasound and thrombus aspirated findings (abstr). Eur Heart J 29 Suppl (2008) 127
Manterola F.A., Perez-Vizcayno M.J., Ruiz M., et al. Coronary aneurysms after drug-eluting stent implantation. Clinical, angiographic and intravascular ultrasound findings (abstr). Eur Heart J 29 Suppl (2008) 12
Mohr F.W., and Serruys P.w. The SYNergy between Percutaneous Coronary Intervention and Cardiac Surgery (SYNTAX) Study. Paper presented at: European Society of Cardiology Congress; September 1 (2008) Munich, Germany
Kapur A. Coronary Artery Revascularization in Diabetes. The CARDia trial. Paper presented at: European Society of Cardiology Congress; September 1 (2008) Munich, Germany
Windecker S., Serruys P.W., Wandel S., et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularization (LEADERS): a randomised non-inferiority trial. Lancet 372 (2008) 1163-1173
Poldermans D. Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery. Results from a randomized placebo controlled trial: DECREASE III. Paper presented at: European Society of Cardiology Congress; September 1 (2008) Munich, Germany
Van de Werf F. Acute coronary syndromes with ST-elevation. Paper presented at: European Society of Cardiology Congress; September 1 (2008) Munich, Germany
Van't Hof A.W., Ten Berg J., Heestermans T., et al., Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 Study Group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet 372 (2008) 537-546
Stone G.W., Witzenbichler B., Guagliumi G., et al., HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
Morrow D.A., Wiviott S.D., Murphy S.A., Mccabe C.H., Antman E.M., and Braunwald E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the TRITON-TIMI 38 trial (abstr). Eur Heart J 29 Suppl (2008) 746
Eikelboom J., Anderson J., Hirsh J., et al. Anticoagulant intensity of enoxaparin compared with fondaparinux in the OASIS-5 trial (abstr). Eur Heart J 29 Suppl (2008) 746
Atar D. A Multicenter, Double blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 on Ischemia Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary intervention (The F.I.R.E. trial). Paper presented at: European Society of Cardiology Congress; September 2 (2008) Munich, Germany
Erbs S. Vascular dysfunction in obese children. Paper presented at: European Society of Cardiology Congress; September 1 (2008) Munich, Germany
Pasterkamp G., Moll F., Hellings W., de Vries J.P., Ozsarlak-Sozer G., and de Kleijn D. Local atherosclerotic plaque osteopontin is a prognostic biomarker for adverse cardiovascular events in heart, brain and periphery (abstr). Eur Heart J 29 Suppl (2008) 276-277
Wijns W. The effects on the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque. Paper presented at: European Society of Cardiology Congress; September 2 (2008) Munich, Germany
The TRANSCEND Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet (2008) Aug 29 [E-pub ahead of print]
Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., and Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
Yusuf S., Teo K.K., Pogue J., et al., The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
Grundtvig M. Impact on nurse-based heart failure clinics on drug management and hospital admissions by self monitoring through a common database. Paper presented at: European Society of Cardiology Congress; September 3 (2008) Munich, Germany
Romero-Corral A., Somers V.K., Boarin S., et al. Increased cardiovascular mortality in women with normal weight obesity (abstr). Eur Heart J 29 Suppl (2008) 266
Fosboel E., Gislason G.H., Abildstrom S.Z., et al. Risk of myocardial infarction and death associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide study (abstr). Eur Heart J 29 Suppl (2008) 124
Sonnenschein K., Mueller M., Horvath T., et al. Exercise training restores anti-inflammatory properties of high-density-lipoprotein (HDL) in patients with metabolic syndrome (abstr). Eur Heart J 29 Suppl (2008) 97
Gielen S., Sandri M., Adams V., et al. Catabolic-anabolic imbalance in the skeletal muscle of heart failure patients: effects of an aerobic training program on protein catabolism (abstr). Eur Heart J 29 Suppl (2008) 531-532
Olsen M.H., Sehestedt T., Jeppesen K., et al. Markers of subclinical vascular damage may improve HeartScore risk stratification and reduce the number of candidates for primary prevention (abstr). Eur Heart J 29 Suppl (2008) 220
Meyer P., Kossowsky M., Kayser B., et al. Stair instead of elevator use at work: cardiovascular preventive effects on healthy employees. The Geneva stair study (abstr). Eur Heart J 29 Suppl (2008) 385-386
Benito B., Brugada R., Berruezo A., et al. A mutation in the sodium channel responsible for the association of long-QT syndrome and familial atrial fibrillation (abstr). Eur Heart J 29 Suppl (2008) 739
Ohno S., Toyoda F., Zankov D., et al. Novel KCNE3 mutation reduced repolarizing potassium current and caused long QT syndrome (abstr). Eur Heart J 29 Suppl (2008) 161
Barth A.S., Halperin V., Aiba T., et al. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level (abstr). Eur Heart J 29 Suppl (2008) 771-772
Santinelli V., Radinovic A., Vicedomini G., et al. Irrigated-tip magnetic ablation. The first human experience in patients undergoing remote ablation for atrial fibrillation (abstr). Eur Heart J 29 Suppl (2008) 399
Chun K.J., Koektuerk B., Schmidt B., et al. Initial experience using the novel 3.5 mm magnetic irrigated tip catheter for magnetically navigated remote pulmonary vein isolation (abstr). Eur Heart J 29 Suppl (2008) 399
Badger T.J., Oakes R.S., Segerson N., et al. Using 3D delayed-enhancement MRI to identify gap lesions following failed pulmonary vein isolation to help guide repeat radiofrequency ablation in atrial fibrillation patients (abstr). Eur Heart J 29 Suppl (2008) 735
Gaspar T., Piorkowski C., Staab C., et al. Role of intraesophageal temperature monitoring to prevent esophageal injury during AF catheter ablation (abstr). Eur Heart J 29 Suppl (2008) 400
Romanov A., Pokuschalov E., Shugaev P., et al. Catheter ablation of left atrial ganglionate plexi: long-term results (abstr). Eur Heart J 29 Suppl (2008) 735
Roy D., Talajic M., Nattel S., et al., Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358 (2008) 2667-2677
Neumann T., Kuniss M., Berkowitsch A., et al. Significance of very early and early recurrences of atrial fibrillation after PVI (abstr). Eur Heart J 29 Suppl (2008) 542-543
Fichtner S., Reents T., Uecer E., et al. Very late relapse of paroxysmal atrial fibrillation after pulmonary vein isolation: incidence and results of repeat ablation (abstr). Eur Heart J 29 Suppl (2008) 257
Taborsky M., Neuzil P., and Balak J. Magnetically guided left ventricular lead implantation based on image integration of angiography and 3-D CT reconstruction of the coronary sinus (abstr). Eur Heart J 29 Suppl (2008) 131
Ricci R., Landolina M., Lunati M., et al. Remote device monitoring and heart failure management of CRT-ICD patients (abstr). Eur Heart J 29 Suppl (2008) 131
Mabo P., Laviolle B., Leclercq C., et al. Cardiac resynchronisation therapy in elderly patients: outcome data. A secondary analysis of CARE-HF (abstr). Eur Heart J 29 Suppl (2008) 3
Cleland J.G.F., Calvert M.J., Verboven Y., and Freemantle N. Effects of cardiac resynchronisation therapy on long-term quality of life, length of hospital stay and survival (the patient journey), an analysis from the CARE-HF study (abstr). Eur Heart J 29 Suppl (2008) 813-814
Bax J.J., Monaghan M., Peraldo C., et al. Cardiac resynchronization therapy in heart failure patients with narrow QRS complexes: results of a PROSPECT sub-study (abstr). Eur Heart J 29 Suppl (2008) 815
Vester E.G., Stellbrink C., and De Haan F. Low penetration of device therapy in CRT/ICD indicated patients and related long term outcome: final results on 3,148 patients from the CRediT heart failure registry (abstr). Eur Heart J 29 Suppl (2008) 816
Scicluna B.P., Remme C.A., Verkerk A.O., et al. The sodium channel auxiliary subunit SCN4B acts as a genetic modifier of cardiac sodium channel disease (abstr). Eur Heart J 29 Suppl (2008) 18
Condorelli G. Targeting micro-RNA as novel treatment modality. Paper presented at: European Society of Cardiology Congress; August 31 (2008) Munich, Germany
Abdellatif M. MicroRNA, new players in gene regulation and cardiac development. Paper presented at: European Society of Cardiology Congress; August 31 (2008) Munich, Germany
Thum T., Gross C., Fiedler J., et al. Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist (abstr). Eur Heart J 29 Suppl (2008) 128
Linsel-Nitschke P., Goetz A., Peters A., et al. Genetic variation at chromosome 1p13.3 modulates low density lipoprotein levels and risk of coronary artery disease across multiple populations (abstr). Eur Heart J 29 Suppl (2008) 790
Braund P.S., Erdmann J., Tobin M.D., et al. A recently identified genetic variant for coronary artery disease risk on chromosome 1p13.3 in the region of the PSRC1 and CELSR2 genes associates with serum cholesterol (abstr). Eur Heart J 29 Suppl (2008) 790
Erdmann J., Goetz A., Braund P., et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease (abstr). Eur Heart J 29 Suppl (2008) 597
Anderson J.L., Horne B.D., Mower C.P., Muhlestein J.B., Park J.J., and Carlquist J.F. Variants at the 9p21 locus robustly predict angiographic CAD independent of standard risk factors (abstr). Eur Heart J 29 Suppl (2008) 594
Ardissino D., Merlini P.A., Berzuini C., et al. Influence of the 9p21.3 genetic variant rs1333040 on the severity of coronary artery disease in early-onset myocardial infarction (abstr). Eur Heart J 29 Suppl (2008) 114
Merlini P.A., Berzuini C., Mannucci P.M., et al. Genetic variants on chromosomal region 9p21.3 associate with early-onset myocardial infarction (abstr). Eur Heart J 29 Suppl (2008) 112-113
Lobatto M.E., Silvera S., Vucic E., et al. A novel nanomedicine-based treatment for atherosclerosis monitored by multimodality imaging (abstr). Eur Heart J 29 Suppl (2008) 792
Zimmermann O., Wiehe J., Hombach V., et al. Development of a universal nanoparticle based contrast agent for specific antigen detection a proof of principle (abstr). Eur Heart J 29 Suppl (2008) 792
Skajaa T., Cormode D.P., Lobatto M.E., et al. Multimodality molecular imaging of macrophages in atherosclerosis using inorganic-core HDL (abstr). Eur Heart J 29 Suppl (2008) 119
Yeh J.S.M., Sennoga C., Mcconnell E., et al. Molecular imaging of the heart using contrast ultrasound: acoustic quantification of molecular expressions (abstr). Eur Heart J 29 Suppl (2008) 21
